Brief: Dancann Pharma Q3 EBITA Up At DKK 2.3 Mln
30/11/2020 08:03
Nov 30 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* THE INTERIM REPORT 3RD QUARTER 2020 FOR DANCANN PHARMA A/S
IS
HEREBY ENCLOSED
* Q3 EBITA DKK 2.3 MILLION VERSUS DKK 0.3 MILLION YEAR AGO
Source text for Eikon: ID:nWkr9VFqjy
Further company coverage: DANCAN.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874